BGT226 free base
Bgt226 is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.
Product Specifications
CAS Number
915020-55-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
534.53
Molecular Formula
C28H25F3N6O2
Notes
Research use only, not for human use.
Receptor
PI3Kα| PI3Kβ| PI3Kγ| mTOR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
M2352-20Q 50 µg
MAP Kinase p44/42, phosphorylated (Tyr204) (MAPK3/MAPK1, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, ERT1, Extracellular Signal-regulated Kinase 2, ERK-2, MAP Kinase Isoform p42, p42-MAPK, Mitogen-activated Protein Kinase 2, MAP Kinase 2, MAPK 2, ERK2, PRKM1, PRKM2 / Mitogen-activated Protein Kinase 3, MAP Kinase 3, MAPK 3, ERT2, Extracellular Signal-regulated Kinase 1, ERK-1, Insulin-stimulated MAP2 Kinase, MAP Kinase Isoform p44, p44-MAPK, Microtubule-associated Protein 2 Kinase, p44-ERK1, ERK1, PRKM3) discontinued
Ask
View Details 
GTR15241530 1 Vial
Lentiviral mouse Wdr70 shRNA (UAS) - Lentiviral mouse Wdr70 shRNA (UAS) (100)
Ask
View Details 